Cargando…
Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
OBJECTIVE: To evaluate efficacy and safety of intravitreal injections of bevacizumab in the treatment of macular edema secondary to retinal vein occlusion (RVO). METHODS: Prospective study, noncomparative, interventional case series. Twelve consecutive patients (12 eyes) with macular edema associate...
Autores principales: | Gutiérrez, Juan Carlos Mesa, Barquet, Luis Arias, Caminal, Josep Maria, Mitjana, Almolda, Sergi Prades, Domènech, Nùria Planas, Goita, Octavi Pujol, Caso, Marc Rubio, Ginebreda, Jorge Arruga |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699794/ https://www.ncbi.nlm.nih.gov/pubmed/19668432 |
Ejemplares similares
-
Pharmacokinetics of intravitreal bevacizumab (Avastin(®)) in rabbits
por: Sinapis, Christos I, et al.
Publicado: (2011) -
Acute onset of retinal detachment after posterior chamber phakic intraocular lens implantation
por: Domènech, Núria Planas, et al.
Publicado: (2008) -
Intravitreal bevacizumab (Avastin) treatment of diffuse diabetic macular edema in an Indian population
por: Kumar, Atul, et al.
Publicado: (2007) -
Intravitreal bevacizumab (avastin) for circumscribed choroidal hemangioma
por: Mandal, Subrata, et al.
Publicado: (2011) -
Using intravitreal bevacizumab (Avastin(®)) – Indian Scenario
por: Kumar, Atul, et al.
Publicado: (2017)